1149183

Lianyungang Kangle Pharmaceutical Co., Ltd. — FEI 3010728729

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 31, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lianyungang (China)

Additional Details

Mutual Recognition Agreement (MRA)